Related Experiment Videos
Bioavailability of cyclophosphamide from oral formulations
European Journal of Clinical Pharmacology
|January 1, 1984
Summary
Cyclophosphamide (CP) is a widely used cancer drug. This study investigated its oral bioavailability and pharmacokinetics, crucial for effective cancer treatment.
Area of Science:
- Pharmacology
- Oncology
- Drug Development
Background:
- Cyclophosphamide (CP) is an essential alkylating agent used in cancer chemotherapy.
- A narrow therapeutic range necessitates high and consistent oral bioavailability for CP.
- Limited pharmacokinetic data exists for oral CP administration.
Purpose of the Study:
- To investigate the pharmacokinetics of oral cyclophosphamide (CP).
- To establish bioavailability data for oral CP in conventional clinical doses.
Main Methods:
- Development of a sensitive gas chromatographic analytical method.
- Pharmacokinetic analysis of oral CP in human subjects.
Main Results:
- The study enabled the investigation of oral CP pharmacokinetics.
- Sensitive analytical methods are key to understanding drug bioavailability.
Conclusions:
- Pharmacokinetic studies of oral CP are now feasible.
- Understanding CP bioavailability is vital for optimizing cancer therapy.